PERCUTANEOUS CORONARY REVASCULARISATION - THE CURRENT STATE OF THE ART

1 Cohen DJ JC O'Shea Pacchiana CM In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced suppression of the platelet IIb/IIIa receptor with integrilin. Am J Cardiol 2002; 89:6I-4.

2 Ruygrok PN Intracoronary Serruys PW. stenting. From concept to custom. Circulation 1996; 94:882-90.

3 Serruys PW B Van Hout Bonnier H Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352:673-81.

4 Betriu A M Masotti Serra A Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four year follow-up. J Am Coll Cardiol 1999; 34: 1498-506.

5 Kiemeneij F PW Serruys Macaya C Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol 2001; 37:1598-603.

6 Mercado N E Boersma Wijns W Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 2001; 38:645-52.

7 Serruys PW P de Jaegere Kiemeneij F A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331:489-95.

8 Albiero R T Rau Schluter M Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions. Circulation 1997; 96: 2997-3005.

9 Hamm CW C Heeschen Goldmann B Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Englj Med 1999; 340:1623-9.

10The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336:1689-96.

11The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1998; 352:87-92.

12The IMPACT II Investigators. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-ll. Lancet 1997; 349:1422-8.

13 Kereiakes D. Preferential benefit of platelet glycoprotein llb/llla receptor blockade: specific considerations by device and disease state. Am J Cardiol 1998; 81:49E-54E.

14 Schomig A FJ Neumann Kastrati A A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334:1084-9.

15 Love BB J Biller Gent M. Adverse haematological effects of ticlopidine. Prevention, recognition and management. DrugSaf 1998; 19:89-98.

16 Taniuchi M Hl Kurz , LasalaJM. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation 2001; 104:539-43.

17The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial lnvestigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345:494-502.

18Clopidogrel in Unstable Angina to prevent Recurrent Events trial (CURE) lnvestigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCl-CURE study. Lancet 2001; 358:527-33.

19 Blankenship JC AS Hellkamp Aguirre FV Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of 7E3 for the Prevention of lschemic Complications trial. Am J Cardiol 1998; 81:36-40.

20 Rogers C S Parikh Seifert P Endogenous cell seeding: remnant endothelium after stenting enhances vascular repair. Circulation I996; 94:2909-14.

21 Martinez-Elbal L JM Ruiz-Nodar Zueco J Direct coronary stenting versus stenting with balloon predilation: immediate and follow-up results of a multicentre, prospective, randomized study. The DlSCO trial. Direct Stenting of Coronary Arteries. Eur Heart J 2002; 23:633-40.

22 Baim DS M Flatley Caputo R Comparison of PREdilatation vs direct stenting in coronary treatment using the Medtronic AVE S670 Coronary Stent System (the PREDlCT trial). Amj Cardiol 200I; 88: 1364-9.

23 Serruys PW F Unger Sousa JE Randomized comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 200I; 344:1117-24.

24 Takagi T G Stankovic Finci L Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation 2002; 106:698-702.

25 Sirnes PA S Golf Myreng Y Stenting in Chronic Coronary Occlusion (SlCCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996; 28:1444-51.

26Rubartelli P Niccoli L, Verna E Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GlSSOC trial. Gruppo ltaliano di Studio sullo Stent nelle Occlusioni Coronariche. J Am Coll Cardiol 1998; 32:90-6.

27 Buller CE V Dzavik Carere RG Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation 1999; 100:236-42.

28 Erbel R M Haude Hopp HW Coronary artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis stent study group. N Engl J Med 1998; 339:1672-8.

29 Mintz GS R Mehran Waksman R Treatment of instent restenosis. Semin Interv Cardiol 1998; 3: 117-21.

30 Teirstein PS V Massullo Jani S Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336: 1697-703.

31 Waksman R RL White Chan RC lntracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000; 101:2165-71.

32 Leon MB PS Teirstein Moses JW Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Englj Med 2001; 344:250-6.

33 Waksman R AE Raizner ,Yeung AC Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the lNHlBlT randomised controlled trial. Lancet 2002; 359:551-7.

34 Verin V , PopowskiY, de Bruyne B Endoluminal betaradiation therapy for the prevention of coronary restenosis after balloon angioplasty. The dose-finding study group. N Engl J Med 200I; 344:243-9.

3S Costa MA, Sabate M, van der Giessen Late coronary occlusion after intracoronary brachytherapy. Circulation I999; 100:789-92.

36Sousa JE,Abizaid A,Abizaid A Late (two-year) followup from the first-in-man (FlM) experience after implantation of sirolimus-eluting stents. J Am Coll Cardiol 2002; 39 (suppl):21A. (Abstract).

37 Morice MC PW Serruys Sousa JE A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-80.

38 Cucherat M E Bonnefoy ,Tremeau G. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cochrane Database Syst Rev 2000; (2):CD001560.

39 Madsen JK P Grande Saunamaki K Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMl). Danish trial in Acute Myocardial lnfarction. Circulation 1997; 96:748-55.

40The FRlSC lnvestigators. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRlSC ll prospective randomised multicentre study. FRagmin and fast revascularisation during instability in coronary artery disease. lnvestigators. Lancet 1999; 354:701-7.

41The Randomized lntervention Trial of unstable Angina (RlTA) investigators. lnterventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RlTA 3 randomised trial. Lancet 2002; 360: 43-51.

42 Davies RF D Goldberg Forman S Asymptomatic cardiac ischemia pilot (AClP) study two-year follow-up. Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997; 95:2037-43.

43Pitt B,Waters D, Brown WV ei al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus revascularization treatment investigators. N Englj Med 1999; 341:70-6.

44 Ellis SG AM Lincoff Whitlow PL Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting. Am J Cardiol 2002; 89:937-40.

45 Pijls NH B De Bruyne Peels K Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Englj Med 1996; 334:1703-8.

46 Bech GJ B De Bruyne Pijls NH Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 2001; 103:2928-34.

47 Pijls NH B De Bruyne Bech GJ Coronary pressure measurement to assess the hemodynamic significance of serial stenoses within one coronary artery: validation in humans. Circulation 2000; 102:2371-7.

48 Pijls NH V Klauss Siebert U Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation 2002; 105:2950-4.

49De Bruyne B, Hersbach F, Pijls NH Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but ‘normal’ coronary angiography. Circulation 2001; 104:2401-6.

50 Achenbach S W Moshage Ropers D Value of electron beam computed tomography for the non-invasive detection of high grade coronary artery stenoses and occlusions. N Engl] Med 1998; 339:1964-71.

51 Choudhury RP V Fuster Badimon JJ MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol 2002; 22:1065-74.

52 Falk E PK Shah Fuster V C oronary plaque disruption. Circulation 1995; 92:657-71.

53Schoenhagen P Tuzcu M, Ellis SG. Plaque vulnerability, plaque rupture and acute coronary syndromes. Multifocal manifestation of a systemic disease process. Circulation 2002; 106:760-2.

54 Stefanadis C L Diamantopoulos Vlachopoulos C Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation 1999; 99:1965-71.

55 Meier B Plaque Ramamurthy S. sealing by coronary angiolpasty. Cathet Cardiovasc Diagn 1995; 36:295-7.